Authors:
Dr. Joaquin Zacarias Cabeza | MRC Toxicology Unit/University of Cambridge | United Kingdom
Tatyana Chernova | MRC Toxicology Unit/University of Cambridge | United Kingdom
Sara Galavotti | MRC Toxicology Unit/University of Cambridge | United Kingdom
Pierre Cauchy | Max Planck Institute of Immunology and Epigenetics | Germany
Xiao-Min Sun | MRC Toxicology Unit/University of Cambridge | United Kingdom
Andrew Craxton | MRC Toxicology Unit/University of Cambridge | United Kingdom
Fiona Murphy | MRC Toxicology Unit/University of Cambridge | United Kingdom
Ian R Powley | MRC Toxicology Unit/University of Cambridge | United Kingdom
Stefano Grosso | MRC Toxicology Unit/University of Cambridge | United Kingdom
Jonathan Bennett | UHL NHS Trust, Glenfield Hospital | United Kingdom
Apostolos Nakas | UHL NHS Trust, Glenfield Hospital | United Kingdom
Peter Greaves | Department of Cancer Studies, University of Leicester | United Kingdom
Ken Donaldson | MRC/University of Edinburgh, Centre for Inflammation Research | United Kingdom
Dr. Craig Poland | MRC/University of Edinburgh, Centre for Inflammation Research | United Kingdom
Anne E. Willis | MRC Toxicology Unit/University of Cambridge | United Kingdom
Anne E. Willis | MRC Toxicology Unit/University of Cambridge | United Kingdom
Prof. Marion MacFarlane | MRC Toxicology Unit/University of Cambridge | United Kingdom